跳至主要内容
临床试验/ACTRN12617001195347
ACTRN12617001195347
已完成
未知

A comparison-group intervention study of medically supervised clinics for first peanut consumption compared with standard care to evaluate rates of introduction of peanut by 12 months of age in infants at risk of peanut allergy.

Child and Adolescent Health Service0 个研究点目标入组 350 人2017年8月16日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Peanut allergy
发起方
Child and Adolescent Health Service
入组人数
350
状态
已完成
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2017年8月16日
结束日期
2020年8月30日
最后更新
3年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • For the intervention group: Infants between 4 and 11 months of age who have never eaten peanut in solid foods, and are deemed as high\-risk for the development of peanut allergy (classified as any one of the following):
  • Eczema treated with over the counter steroids or prescription medications
  • Allergy to a food other than peanut
  • Food allergy in a parent or sibling
  • Any atopic disease (eczema, asthma, food allergy, or allergic rhinitis/hay fever) in 2 or
  • more first degree relatives (parents/siblings)
  • For infants in the control group: Infants who are at least 12 months of age, have not attended a PIPPA clinic, and are deemed as high\-risk for the development of peanut allergy (classified as any one of the following):
  • Eczema treated with over the counter steroids or prescription medications
  • Allergy to a food other than peanut
  • Food allergy in a parent or sibling

排除标准

  • Infants with significant underlying medical conditions that place them at increased risk
  • of adverse outcomes in the event of an allergic reaction, such as cardiovascular or
  • respiratory diseases. A study doctor will review these infants before enrolling them in
  • Infants who have had previous allergy testing (skin prick or specific IgE testing) for
  • peanut and been advised by, or in consultation with, a paediatrician or allergy specialist
  • to avoid peanut.

结局指标

主要结局

未指定

相似试验